Hospital Universitari Vall d'Hebron ( Site 2005)

Barcelona 08035

0 studies enrolling now · 1 studies all time

What they study most

Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Studies at this site

• A Study to Evaluate Zilovertamab Vedotin (MK-2140) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-004) — Completed